Skip to main content

Table 5 Treatment toxicity

From: A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients

Bone – based image guided group (BB) N = 89

Fiducial – based image guided group (FB) N = 91

 

GI

Number (%)

GI

Number (%)

p

Acute: during treatment and the first 3 months of follow-up

89 (100%)

Acute: during treatment and the first 3 months of follow-up

91 (100%)

0.29

 G0

26 (29.2%)

G0

40 (43.9%)

 

 G1

38 (42.7%)

G1

32 (35.2%)

 

 G2

24 (27.0%)

G2

18 (19.8%)

 

 G3

1 (1.1%)

G3

1 (1.1%)

 

Late: after the third month of follow-up

89 (100%)

Late: after the third month of follow-up

88 (96.7%)

0.90

 G0

51 (57.3%)

G0

53 (60.2%)

 

 G1

26 (29.2%)

G1

20 (22.8%)

 

 G2

9 (10.1%)

G2

11 (12.5%)

 

 G3

3 (3.4%)

G3

4 (4.5%)

 

 GU

Number (%)

GU

Number (%)

p

Acute: during treatment and the first 3 months of follow-up

89 (100%)

Acute: during treatment and the first 3 months of follow-up

91 (100%)

0.33

 G0

18 (20.2%)

G0

22 (24.2%)

 

 G1

32 (36.0%)

G1

27 (29.7%)

 

 G2

34 (38.2%)

G2

41 (45.0%)

 

 G3

5 (5.6%)

G3

1 (1.1%)

 

Late: after the third month of follow-up

89 (100%)

Late: after the third month of follow-up

88 (96.7%)

0.12

 G0

62 (69.7%)

G0

50 (56.8%)

 

 G1

16 (18.0%)

G1

27 (30.7%)

 

 G2

10 (11.2%)

G2

10 (11.4%)

 

 G3

1 (1.1%)

G3

1 (1.1%)